You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
TGA business plan 2014-2015
Therapeutic Goods Administration
The table below summarises the risks faced by TGA that are rated as high:
|Risk name||Risk treatment||Strategic risk theme||New or emerging risk?|
|A product is released onto the Australian market which poses an unacceptable level of risk.||
|Public access to therapeutic products is restricted or delayed.||
- Department fails to meet expectations for delivery of medium to long term health policy reform agenda
- Effective engagement with other government agencies is not maintained and/or engagement with other external stakeholders is not effective.